G D Mellick, O A Ross. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Caffeine/metabolismCytochrome P-450 CYP1A2/geneticsFemaleGenetic Predisposition to Disease/geneticsHumansMaleNeuroprotective Agents/pharmacologyParkinson Disease/geneticsReceptor, Adenosine A2A/genetics
Substances: See more » Neuroprotective AgentsReceptor, Adenosine A2ACaffeineCYP1A2 protein, humanCytochrome P-450 CYP1A2
Year: 2011 PMID: 21281404 DOI: 10.1111/j.1468-1331.2011.03350.x
Source DB: PubMed Journal: Eur J Neurol ISSN: 1351-5101 Impact factor: 6.089